Clinical Trials Directory

Trials / Completed

CompletedNCT04494464

Treatment Rates and Compliance to Treatment in Patients With Familial Hypercholesterolemia

Awareness, Treatment Rates and Compliance to Treatment in Patients With Serum LDL Cholesterol Higher Than 250 mg/dL, and Possible, Probable or Definite Familial Hypercholesterolemia

Status
Completed
Phase
Study type
Observational
Enrollment
367 (actual)
Sponsor
Ankara Yildirim Beyazıt University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers

Summary

Familial hypercholesterolemia is a genetic disease characterized by increased levels of low density lipoprotein cholesterol (LDL-C). It is underdiagnosed and undertreated despite relatively high prevalence and significant association with increased mortality.

Detailed description

Patients older than 18 years old and have a serum low density LDL-C≥250 mg/dL were identified from the hospital database. A questionnaire was completed via phone. Patients were classified as definite, probable and possible familial hypercholesterolemia according to Dutch Lipid Clinical Network Criteria

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2017-01-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2020-07-31
Last updated
2020-07-31

Source: ClinicalTrials.gov record NCT04494464. Inclusion in this directory is not an endorsement.